ArticleOPEN ACCESS

Correction: CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models (Journal for ImmunoTherapy of Cancer (2021) 9 (e002644) DOI: 10.1136/jitc-2021-002644)

Journal for ImmunoTherapy of Cancer
DOI: 10.1136/jitc-2021-002644corr1
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Puigdelloses M, Garcia-Moure M, Labiano S, et al. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. Journal for ImmunoTherapy of Cancer 2021;9:e002644. doi: 10.1136/ jitc-2021-002644 This paper has been updated since first published to amend author name 'Jaime Gállego Pérez-Larraya'.

Cite

CITATION STYLE

APA

Puigdelloses, M., Garcia-Moure, M., & Labiano, S. (2021, August 1). Correction: CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models (Journal for ImmunoTherapy of Cancer (2021) 9 (e002644) DOI: 10.1136/jitc-2021-002644). Journal for ImmunoTherapy of Cancer. BMJ Publishing Group. https://doi.org/10.1136/jitc-2021-002644corr1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free